Aspira Women's Health Inc.
AWHL- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000926617
No open-market purchases or sales by Aspira Women's Health Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Aspira Women's Health Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- −1 vs. Q4 2024
- Shares held
- 864.2K
- −592.9K (−40.7%) vs. Q4 2024
- Total value
- $81.0K
- −$946.5K (−92.1%) vs. Q4 2024
- New holders
- 3
- 9 more added
- Sold out
- 4
- 5 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AWHL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 1 | $392 |
| Q2 2025 | 2 | $15.7K |
| Q1 2025 | 25 | $81.0K |
| Q4 2024 | 26 | $1.03M |
| Q3 2024 | 25 | $1.91M |
| Q2 2024 | 26 | $2.08M |
| Q1 2024 | 23 | $6.15M |
| Q4 2023 | 24 | $2.92M |
| Q3 2023 | 24 | $3.53M |
| Q2 2023 | 22 | $1.75M |
| Q1 2023 | 45 | $3.25M |
| Q4 2022 | 47 | $3.24M |
| Q3 2022 | 58 | $4.46M |
| Q2 2022 | 72 | $7.02M |
| Q1 2022 | 92 | $22.9M |
| Q4 2021 | 98 | $50.9M |
| Q3 2021 | 92 | $97.0M |
| Q2 2021 | 95 | $174.1M |
| Q1 2021 | 97 | $211.5M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Aspira Women's Health Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Danske Bank A/S | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 100 | $0 | 0.00% | +100 | New |
| Group One Trading, L.P. | 119 | $11 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 199 | $19 | 0.00% | +178+847.6% | Added |
| BNP Paribas Arbitrage, SA | 610 | $57 | 0.00% | 00.0% | Unchanged |
| Operose Advisors LLC | 1,000 | $94 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 1,694 | $159 | 0.00% | +78+4.8% | Added |
| JPMorgan Chase & Co | 2,061 | $194 | 0.00% | −3−0.1% | Reduced |
| Advisor Group Holdings, Inc. | 2,650 | $240 | 0.00% | +1,151+76.8% | Added |
| Tower Research Capital LLC (TRC) | 4,130 | $388 | 0.00% | −30−0.7% | Reduced |
| M&T Bank Corp | 14,999 | $1.41K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 16,799 | $1.58K | 0.00% | −11,981−41.6% | Reduced |
| State Street Corp | 19,749 | $1.85K | 0.00% | 00.0% | Unchanged |
| Northeast Financial Consultants Inc | 23,436 | $2.20K | 0.00% | 00.0% | Unchanged |
| The PNC Financial Services Group, Inc. | 25,000 | $2.35K | 0.00% | +10,000+66.7% | Added |
| Two Sigma Securities, LLC | 29,808 | $2.80K | 0.00% | +8,279+38.5% | Added |
| Pine Valley Investments Ltd Liability Co | 33,400 | $3.14K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 34,196 | $3.21K | 0.00% | +32,151+1,572.2% | Added |
| Virtu Financial LLC | 52,851 | $5.00K | 0.00% | +40,543+329.4% | Added |
| XTX Topco Ltd | 62,184 | $5.84K | 0.00% | +62,184 | New |
| Bank of America Corp | 63,528 | $5.91K | 0.00% | +5,221+9.0% | Added |
| Vanguard Group Inc | 79,183 | $7.44K | 0.00% | −194,906−71.1% | Reduced |
| BlackRock, Inc. | 82,232 | $7.72K | 0.00% | −535−0.6% | Reduced |
| Geode Capital Management, LLC | 131,968 | $12.4K | 0.00% | +33,860+34.5% | Added |
| HRT Financial LP | 182,286 | $17.0K | 0.00% | +182,286 | New |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −710,000−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −29,616−100.0% | Sold out |
| Quantum Private Wealth, LLC | 0 | $0 | 0.00% | −21,799−100.0% | Sold out |
| Global Wealth Strategies & Associates | 0 | $0 | 0.00% | −18−100.0% | Sold out |